These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2530825)

  • 21. Asymptomatic colorectal neoplasia and fecal characteristics: a case-control study of subjects participating in the nottingham fecal occult blood screening trial.
    Little J; Owen RW; Fernandez F; Hawtin PG; Hill MJ; Logan RF; Thompson MH; Hardcastle JD
    Dis Colon Rectum; 2002 Sep; 45(9):1233-41. PubMed ID: 12352242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fundamental studies and clinical evaluation of fecal occult blood by immunological detection].
    Yoshida R; Ishikawa Y; Yamanaka T; Tani E; Ono N; Fukumoto K
    Rinsho Byori; 1989 Jan; 37(1):63-6. PubMed ID: 2657138
    [No Abstract]   [Full Text] [Related]  

  • 23. [Detection and mass - screening programs of colorectal cancer].
    Gornet JM
    Pathol Biol (Paris); 2004 Apr; 52(3):115-6. PubMed ID: 15063927
    [No Abstract]   [Full Text] [Related]  

  • 24. [Detection of fecal occult blood and colorectal cancer].
    Herrerías Gutiérrez JM; Caunedo Alvarez JM; Herrerías Esteban JM
    Rev Esp Enferm Dig; 1999 May; 91(5):331-4. PubMed ID: 10362874
    [No Abstract]   [Full Text] [Related]  

  • 25. Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study.
    Li S; Nie Z; Li N; Li J; Zhang P; Yang Z; Mu S; Du Y; Hu J; Yuan S; Qu H; Zhang T; Wang S; Dong E; Qi D
    Chin Med J (Engl); 2003 Feb; 116(2):200-2. PubMed ID: 12775229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The detection of colorectal cancer at an asymptomatic stage by screening is useful.
    Komuta K; Furui J; Haraguchi M; Kanematsu T
    Hepatogastroenterology; 2000; 47(34):1011-4. PubMed ID: 11020866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Economic evaluation of colorectal cancer screening with fecal occult blood detection].
    Maté Jiménez J
    Rev Esp Enferm Dig; 2000 Nov; 92(11):764-5. PubMed ID: 11468859
    [No Abstract]   [Full Text] [Related]  

  • 29. Colorectal cancer screening: in your office now?
    Burge F
    Can Fam Physician; 2003 Jul; 49():903. PubMed ID: 12901488
    [No Abstract]   [Full Text] [Related]  

  • 30. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan.
    Saito H
    J Med Screen; 2006; 13 Suppl 1():S6-7. PubMed ID: 17227634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective comparative evaluation of an office-based rapid immunological test with a Guaiac-based fecal occult blood test for colorectal cancer screening in general population with average-risk.
    Shastri YM; Loitsch S; Nowak R; Povse N; Stein J
    Clin Lab; 2008; 54(9-10):385-7. PubMed ID: 19097496
    [No Abstract]   [Full Text] [Related]  

  • 32. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for colorectal cancer by faecal occult blood test: why people choose to refuse.
    Worthley DL; Cole SR; Esterman A; Mehaffey S; Roosa NM; Smith A; Turnbull D; Young GP
    Intern Med J; 2006 Sep; 36(9):607-10. PubMed ID: 16911554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal cancer screening: now is the time.
    Winawer SJ; Zauber AG
    CMAJ; 2000 Sep; 163(5):543-4; discussion 548. PubMed ID: 11006765
    [No Abstract]   [Full Text] [Related]  

  • 35. Colorectal cancer screening in Scotland.
    Steele RJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S33-4. PubMed ID: 18368639
    [No Abstract]   [Full Text] [Related]  

  • 36. The place of fecal occult blood test in colorectal cancer screening in 2006: the U.S. perspective.
    Bond JH
    Am J Gastroenterol; 2006 Feb; 101(2):219-21. PubMed ID: 16454821
    [No Abstract]   [Full Text] [Related]  

  • 37. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
    Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
    Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Participation and medical follow-up in screening of colorectal cancer in France within the SU.VI.MAX study].
    Cailhol J; Czernichow S; Mennen L; Boutron-Ruault MC; Zarebska M; Franchisseur C; Preziosi P; Galan P; Hercberg S
    Rev Epidemiol Sante Publique; 2002 Jun; 50(3):321-3. PubMed ID: 12122348
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.
    Hoepffner N; Shastri YM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
    Aliment Pharmacol Ther; 2006 Jan; 23(1):145-54. PubMed ID: 16393292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms.
    Dancourt V; Lejeune C; Lepage C; Gailliard MC; Meny B; Faivre J
    Eur J Cancer; 2008 Oct; 44(15):2254-8. PubMed ID: 18760592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.